FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns the use of compositions for preparing a drug for treating or preventing zygomycosis. The compositions contains at least one iron-chelating compound. Also, the compositions may additionally contain at least one antimycotic agent. The iron-chelating compounds are represented by the compounds other than siderophore or xenosiderophore with respect to the given fungoid diseases, namely deferiprone and deferasirox. The antimycotic agents being parts of the compositions may contain polyene azol or echinocandin antimycotic agents.
EFFECT: inventions are used for treating or relieving the severity of the fungoid diseases.
3 tbl, 9 ex, 14 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF COMPOUNDS IN TREATING FUNGAL INFECTIONS | 2021 |
|
RU2805930C1 |
| COMPOUNDS AND METHODS FOR TREATING FUNGAL INFECTIONS | 2021 |
|
RU2824066C1 |
| AGENT FOR TREATING BODY IRON OVERLOAD, OR HAEMOCHROMATOSIS | 2014 |
|
RU2557959C1 |
| NOVEL ANTIFUNGAL COMPOUND 2-(3,4-DIMETHYL-2,5-DIHYDRO-1H-PYRROLE-2-YL)-1-METHYLETHYL PENTANOATE | 2002 |
|
RU2294923C2 |
| NOVEL DOSAGE FORM FOR TREATING MYCOTIC INFECTION | 2010 |
|
RU2481100C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING MYCOTIC LESIONS OF MUCOUS MEMBRANES | 2016 |
|
RU2705098C2 |
| USE OF HUMAN LACTOFERRIN APO FORM AS ANTIHYPOXANT AND HYPOXIA INDUCIBLE FACTOR-1 ALPHA STABILISER | 2011 |
|
RU2465004C1 |
| ANTIFUNGAL SEMI-SYNTHETIC POLYENE ANTIBIOTIC, WATER-SOLUBLE SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS BASED THEREON | 2018 |
|
RU2688658C1 |
| ANTIFUNGAL AGENTS | 2015 |
|
RU2727520C2 |
| TREATMENT OF MYCOTIC INFECTION WITH ANTIMYCOTIC PREPARATIONS OUT OF POLYENIC GROUP OR THAT OF BETA-GLUCANSINTASE INHIBITORS IN COMBINATION WITH ANTI-hsp90-ANTIBODIES | 2001 |
|
RU2262952C2 |
